QCM
ZVRA icon

Quantinno Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

Quantinno Capital Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
49,636
+17,614
+55% +$196K ﹤0.01% 2790
2026
Q1 		$298K Buy
32,022
+17,065
+114% +$154K ﹤0.01% 3030
2025
Q4 		$134K Buy
14,957
+447
+3% +$4.23K ﹤0.01% 3105
2025
Q3 		$138K Buy
14,510
+4,032
+38% +$40.4K ﹤0.01% 2845
2025
Q2 		$92.3K Buy
+10,478
New +$85K ﹤0.01% 2521

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantinno Capital Management's ZVRA Position: Q2 2026 in Review

Quantinno Capital Management increased its Zevra Therapeutics (ZVRA) stake by 55% in Q2 2026, buying an estimated $196K and bringing the position to 49,636 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

Quantinno Capital Management first reported a position in ZVRA in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Quantinno Capital Management held 49,636 shares of Zevra Therapeutics worth $712K as of Q2 2026.
  • Quantinno Capital Management bought 17,614 Zevra Therapeutics shares in Q2 2026, an estimated $196K.
  • Zevra Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2790 holding.
  • Quantinno Capital Management first reported a position in Zevra Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.